Aug 5, 2026 08:00AM
Jul 15, 2026 08:00AM
Jul 15, 2026 08:00AM
Jul 9, 2026 06:49AM
Jul 8, 2026 08:02AM
Jul 8, 2026 08:00AM
Jun 5, 2026 08:00AM UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 3, 2026 06:53AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
May 15, 2026 08:00AM
May 15, 2026 08:00AM
May 13, 2026 08:02AM
May 13, 2026 08:00AM ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
May 11, 2026 07:12AM
May 6, 2026 08:00AM
Mar 30, 2026 08:05AM
Mar 30, 2026 08:00AM
Mar 6, 2026 04:10PM
Mar 2, 2026 08:04AM
Mar 2, 2026 08:00AM UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 27, 2026 08:30AM
Feb 24, 2026 04:05PM
Feb 23, 2026 08:00AM
Feb 4, 2026 08:00AM
Jan 5, 2026 08:00AM
Dec 22, 2025 07:06AM
Dec 5, 2025 08:00AM UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2025 08:00AM
Nov 6, 2025 07:58AM
Nov 6, 2025 07:58AM
Nov 4, 2025 08:00AM
Oct 30, 2025 08:00AM
Oct 27, 2025 08:00AM
Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
Oct 2, 2025 08:02AM
Oct 2, 2025 08:00AM
Sep 8, 2025 08:00AM
Aug 21, 2025 08:00AM
Aug 19, 2025 06:18AM
Aug 7, 2025 08:00AM
Aug 5, 2025 08:00AM UroGen reports 72% response durability for bladder cancer drug
Aug 5, 2025 08:00AM
Jul 29, 2025 08:00AM
Jul 28, 2025 08:00AM
Jul 28, 2025 08:00AM
Jul 21, 2025 08:05AM
Jul 21, 2025 08:00AM
Jul 8, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
Jul 7, 2025 08:04AM

328,164 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All